High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. (Q53243561)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2007

Language	Label	Description	Also known as
English	High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.	scientific article published in March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ross Smith

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

AiQun Xue

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

Anthony Gill

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

Christopher Scarlett

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

Alexander Saxby

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

Adele Clarkson

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

Thomas Hugh

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

publication date

1 March 2007

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

World Journal of Surgery

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

31

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

493-502; discussion 503

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

https://scigraph.springernature.com/pub.10.1007/s00268-006-0289-9

0 references

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00268-006-0289-9

21 January 2018

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted alpha therapy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase-type plasminogen activator system in prostate cancer metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The plasminogen-plasmin system in malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase plasminogen activator system: role in malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primer3 on the WWW for general users and for biologist programmers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 1997.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasion and metastasis in pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A white paper: the product of a pancreas cancer think tank

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases in tumor invasion and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00268-006-0289-9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17219285

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53243561&oldid=1517912252"